Circulating Cell Free DNA Integrity Index as a Biomarker for Response to Chemotherapy in Patients with Metastatic Colorectal Carcinoma

OBJECTIVE: Assessing plasma Cell Free DNA (cfDNA) integrity index as a biomarker for response prediction and early response evaluation in mCRC patients receiving chemotherapy, in comparison to Carcinoembryonic antigen (CEA) and Carbohydrate antigen 19-9 (CA19-9), to be used as an additional tool to...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskander, Nancy Samir, Mansour, Lamia, Abdelaal, Amaal, Saad, Ehab, Mohamed, Doaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258663/
https://www.ncbi.nlm.nih.gov/pubmed/35092403
http://dx.doi.org/10.31557/APJCP.2022.23.1.339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258663/
https://www.ncbi.nlm.nih.gov/pubmed/35092403
http://dx.doi.org/10.31557/APJCP.2022.23.1.339

Ejemplares similares